Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy Volunteers|Breast Cancer
Interventions: BIOLOGICAL: [131I]-SGMIB Anti-HER2 VHH1
Sponsor: Precirix